##gff-version 3
##sequence-region Q13351 1 362
Q13351	UniProtKB	Chain	1	362	.	.	.	ID=PRO_0000047160;Note=Krueppel-like factor 1	
Q13351	UniProtKB	Zinc finger	279	303	.	.	.	Note=C2H2-type 1;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00042	
Q13351	UniProtKB	Zinc finger	309	333	.	.	.	Note=C2H2-type 2;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00042	
Q13351	UniProtKB	Zinc finger	339	361	.	.	.	Note=C2H2-type 3;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00042	
Q13351	UniProtKB	Compositional bias	1	263	.	.	.	Note=Pro-rich	
Q13351	UniProtKB	Compositional bias	61	76	.	.	.	Note=Asp/Glu-rich (acidic)	
Q13351	UniProtKB	Modified residue	23	23	.	.	.	Note=Phosphothreonine%3B by CK2;Ontology_term=ECO:0000250,ECO:0000305;evidence=ECO:0000250|UniProtKB:P46099,ECO:0000305	
Q13351	UniProtKB	Modified residue	184	184	.	.	.	Note=Omega-N-methylarginine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P46099	
Q13351	UniProtKB	Modified residue	274	274	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P46099	
Q13351	UniProtKB	Modified residue	288	288	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P46099	
Q13351	UniProtKB	Cross-link	54	54	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q13351	UniProtKB	Natural variant	5	5	.	.	.	ID=VAR_074272;Note=E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24829204;Dbxref=dbSNP:rs483352842,PMID:24829204	
Q13351	UniProtKB	Natural variant	102	102	.	.	.	ID=VAR_043981;Note=S->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15489334,ECO:0000269|PubMed:21055716;Dbxref=dbSNP:rs2072597,PMID:15489334,PMID:21055716	
Q13351	UniProtKB	Natural variant	182	182	.	.	.	ID=VAR_043982;Note=F->L;Dbxref=dbSNP:rs2072596	
Q13351	UniProtKB	Natural variant	298	298	.	.	.	ID=VAR_072737;Note=Found in a patient with autosomal recessive microcytic hypochromic anemia and increased fetal hemoglobin%3B compound heterozygous with a frameshift mutation of the same gene%3B unknown pathological significance%3B no effect on protein abundance%3B no effect on protein localization%3B decreased transcriptional activity. A->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:24829204,ECO:0000269|PubMed:25585695;Dbxref=dbSNP:rs387907598,PMID:24829204,PMID:25585695	
Q13351	UniProtKB	Natural variant	299	299	.	.	.	ID=VAR_074273;Note=H->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24829204;Dbxref=dbSNP:rs137852688,PMID:24829204	
Q13351	UniProtKB	Natural variant	299	299	.	.	.	ID=VAR_058108;Note=In blood group-In(Lu). H->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18487511;Dbxref=dbSNP:rs137852688,PMID:18487511	
Q13351	UniProtKB	Natural variant	316	316	.	.	.	ID=VAR_074274;Note=C->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25690802;Dbxref=PMID:25690802	
Q13351	UniProtKB	Natural variant	325	325	.	.	.	ID=VAR_064901;Note=In CDAN4%3B has a dominant-negative effect on the transcriptional activation of CD44 and AQP1 promoters. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21055716;Dbxref=dbSNP:rs267607201,PMID:21055716	
Q13351	UniProtKB	Natural variant	328	328	.	.	.	ID=VAR_058109;Note=In blood group-In(Lu). R->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18487511;Dbxref=dbSNP:rs140252918,PMID:18487511	
Q13351	UniProtKB	Natural variant	328	328	.	.	.	ID=VAR_058110;Note=In blood group-In(Lu). R->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18487511;Dbxref=PMID:18487511	
Q13351	UniProtKB	Natural variant	331	331	.	.	.	ID=VAR_058111;Note=In blood group-In(Lu). R->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18487511;Dbxref=PMID:18487511	
Q13351	UniProtKB	Natural variant	334	334	.	.	.	ID=VAR_074275;Note=T->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24829204;Dbxref=dbSNP:rs483352841,PMID:24829204	
Q13351	UniProtKB	Natural variant	338	338	.	.	.	ID=VAR_072738;Note=Found in a patient with autosomal recessive microcytic hypochromic anemia and increased fetal hemoglobin%3B with microcytic hypochromic anemia%3B compound heterozygous with a frameshift mutation of the same gene%3B no effect on protein abundance%3B no effect on protein localization%3B decreased transcriptional activity. P->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25585695;Dbxref=dbSNP:rs387907599,PMID:25585695	
Q13351	UniProtKB	Natural variant	341	341	.	.	.	ID=VAR_074276;Note=C->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24829204;Dbxref=dbSNP:rs483352839,PMID:24829204	
Q13351	UniProtKB	Sequence conflict	163	163	.	.	.	Note=A->G;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q13351	UniProtKB	Sequence conflict	173	173	.	.	.	Note=P->A;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q13351	UniProtKB	Sequence conflict	184	184	.	.	.	Note=R->G;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q13351	UniProtKB	Sequence conflict	192	192	.	.	.	Note=A->E;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q13351	UniProtKB	Helix	24	35	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2MBH	
Q13351	UniProtKB	Beta strand	64	67	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2L2I	
Q13351	UniProtKB	Beta strand	70	75	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2L2I	
